FTC allows Amgen to move forward with $27.8 billion Horizon Therapeutics acquisition

The FTC had filed a lawsuit in May seeking to block the acquisition, arguing that the deal would "stifle competition" in the pharmaceutical industry.

from Health and Science https://ift.tt/9KWM2xc
https://ift.tt/wTJjS5D
https://ift.tt/OqxLouF